Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Baxalta Incorporated Common Sto (BXLT)

Baxalta Incorporated Common Sto (BXLT)
46.02 -0.18 (-0.39%) 06/02/16 [NYSE]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Jun 2nd, 2016
Day Low
46.01
Day High
46.52
Open 46.27
Previous Close 46.20 46.20
Volume 228,648,297 228,648,297
Avg Vol 24,994,385 24,994,385
Stochastic %K 89.57% 89.57%
Weighted Alpha +50.40 +50.40
5-Day Change +0.31 (+0.70%) +0.31 (+0.70%)
52-Week Range 29.83 - 46.52 29.83 - 46.52
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,579,550
  • Shares Outstanding, K 683,080
  • Annual Sales, $ 6,148 M
  • Annual Income, $ 956,000 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 4.37
  • Price/Cash Flow 18.63
  • Price/Book 7.45
  • Price/Earnings ttm 23.10
  • Earnings Per Share ttm 2.00
  • Most Recent Earnings $0.47 on 04/28/16
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.28 (0.61%)
  • Most Recent Dividend 0.070 on 03/08/16
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/16
See More
  • Average Estimate 0.52
  • Number of Estimates 2
  • High Estimate 0.53
  • Low Estimate 0.52
  • Prior Year 0.40
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.67 +13.15%
on 05/06/16
Period Open: 42.14
46.52 -1.07%
on 06/02/16
+3.88 (+9.21%)
since 05/02/16
3-Month
37.44 +22.92%
on 03/16/16
Period Open: 39.90
46.52 -1.07%
on 06/02/16
+6.12 (+15.34%)
since 03/02/16

Business Summary

Baxalta Incorporated is a biopharmaceutical company which is engaged in developing, manufacturing and commercializing transformative therapies to treat orphan and underserved disease conditions in hematology, immunology and oncology. Baxalta Incorporated is based in Deerfield, United States.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 46.69
1st Resistance Point 46.36
Last Price 46.02
1st Support Level 45.85
2nd Support Level 45.67
3rd Support Level N/A

See More

52-Week High 46.52
Last Price 46.02
Fibonacci 61.8% 40.14
Fibonacci 50% 38.17
Fibonacci 38.2% 36.21
52-Week Low 29.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar